Researchers estimate that expanding access to weight-loss drugs could save over 50,000 lives annually, reducing obesity rates ...

Hims stock has rallied almost 22% this week on enthusiasm after the FDA said it will allow compounded versions of Lilly's ...

The Alliance for Pharmacy Compounding (APC) wants clarity around the FDA’s decision to reconsider tirzepatide’s removal from ...

In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

There have been two really troubling stories over the past week involving the Government’s welfare gimmicks. First up, health secretary Wes Streeting this week announced a new collaboration with Lilly ...

A group of health professionals have called for a review of obesity management services in light of increased public demand ...

Eighty states, cities, counties, school boards and unions have joined litigation in a New Jersey district court against the three major pharmacy middlemen.

Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more like ...

On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of the wildly popular drug.

I don’t think suddenly we’ve got X amount of unemployed people and we all give them Mounjaro and once they start losing ...

Adam Green, chief executive of unemployment charity Yes Manchester, said obesity was low on the list of reasons why some ...

,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is ...